异常肿瘤血管系统与血管生成：癌症治疗的新机遇 - Suppr

Suppr

超能文献

Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.

作者信息

Zhu Zhenping

机构信息

Department of Antibody Technology, ImClone Systems, 180 Varick Street, New York, NY 10014, USA.

出版信息

Drug Discov Today. 2003 Sep 15;8(18):827-8. doi: 10.1016/s1359-6446(03)02763-6.

DOI:10.1016/s1359-6446(03)02763-6

PMID:12963316

Abstract

摘要

相似文献

Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.

Drug Discov Today. 2003 Sep 15;8(18):827-8. doi: 10.1016/s1359-6446(03)02763-6.

Targeting tumor vasculature: reality or a dream?

J Drug Target. 2002 Nov;10(7):529-33. doi: 10.1080/1061186021000051062.

[Targeting blood vessels for treatment of cancer...].

J Pharm Belg. 2003;58(3):79-80.

Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.

J Clin Neurosci. 2009 Sep;16(9):1119-30. doi: 10.1016/j.jocn.2009.02.009. Epub 2009 Jun 24.

Therapeutic targeting of the tumor vasculature.

Semin Radiat Oncol. 2004 Jul;14(3):222-32. doi: 10.1016/j.semradonc.2004.04.009.

Antiangiogenesis: new frontiers in therapeutic development.

Angiogenesis. 2005;8(4):285-7. doi: 10.1007/s10456-005-9025-6. Epub 2006 Jan 7.

Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.

Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):241-53. doi: 10.2174/1568008013341073.

Antiangiogenic tumor therapy.

Biotechniques. 2003 May;34(5):1048-50, 1052, 1054 passim. doi: 10.2144/03345dd01.

Abstracts of the 1st European Conference on Tumor Angiogenesis and Antiangiogenic Therapy. Munich, Germany, 1-3 October 2004.

Angiogenesis. 2004;7 Suppl 1:1-53.

[Angiogenesis in cancer].

Medicina (B Aires). 2002;62(6):604-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.

Drug Discov Today. 2003 Sep 15;8(18):827-8. doi: 10.1016/s1359-6446(03)02763-6.

Targeting tumor vasculature: reality or a dream?

J Drug Target. 2002 Nov;10(7):529-33. doi: 10.1080/1061186021000051062.

[Targeting blood vessels for treatment of cancer...].

J Pharm Belg. 2003;58(3):79-80.

Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.

J Clin Neurosci. 2009 Sep;16(9):1119-30. doi: 10.1016/j.jocn.2009.02.009. Epub 2009 Jun 24.

Therapeutic targeting of the tumor vasculature.

Semin Radiat Oncol. 2004 Jul;14(3):222-32. doi: 10.1016/j.semradonc.2004.04.009.

Antiangiogenesis: new frontiers in therapeutic development.

Angiogenesis. 2005;8(4):285-7. doi: 10.1007/s10456-005-9025-6. Epub 2006 Jan 7.

Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.

Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):241-53. doi: 10.2174/1568008013341073.

Antiangiogenic tumor therapy.

Biotechniques. 2003 May;34(5):1048-50, 1052, 1054 passim. doi: 10.2144/03345dd01.

Abstracts of the 1st European Conference on Tumor Angiogenesis and Antiangiogenic Therapy. Munich, Germany, 1-3 October 2004.

Angiogenesis. 2004;7 Suppl 1:1-53.

[Angiogenesis in cancer].

Medicina (B Aires). 2002;62(6):604-6.